STOCK TITAN

ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

ProPhase Labs announced the launch of DNA Complete, offering comprehensive whole genome sequencing with health, wellness, and ancestry insights. The service includes advanced bioinformatics, genetic counseling, and a subscription model. Additionally, they introduced DNA Expand, allowing users to enhance existing DNA ancestry data with 50x more information through a $49.95 annual subscription.

The company appointed Stu Hollenshead, former Barstool Sports executive, to lead marketing efforts and plans an influencer-driven campaign. The service targets a market of over 26 million people who have undergone genetic ancestry testing, with DNA Expand specifically focusing on existing ancestry test customers.

ProPhase Labs ha annunciato il lancio di DNA Complete, che offre un sequenziamento genomico completo con informazioni su salute, benessere e origine. Il servizio include bioinformatica avanzata, consulenza genetica e un modello in abbonamento. Inoltre, hanno presentato DNA Expand, che consente agli utenti di ampliare i dati di origine genetica esistenti con 50 volte più informazioni tramite un abbonamento annuale di $49.95.

L'azienda ha nominato Stu Hollenshead, ex dirigente di Barstool Sports, per guidare gli sforzi di marketing e prevede una campagna guidata da influencer. Il servizio si rivolge a un mercato di oltre 26 milioni di persone che hanno effettuato test di origine genetica, con DNA Expand che si concentra specificamente sui clienti di test di origine esistenti.

ProPhase Labs anunció el lanzamiento de DNA Complete, que ofrece secuenciación del genoma completo con información sobre salud, bienestar y ascendencia. El servicio incluye bioinformática avanzada, asesoramiento genético y un modelo de suscripción. Además, presentaron DNA Expand, que permite a los usuarios ampliar los datos de ascendencia genética existentes con 50 veces más información a través de una suscripción anual de $49.95.

La compañía nombró a Stu Hollenshead, ex ejecutivo de Barstool Sports, para liderar los esfuerzos de marketing y planea una campaña impulsada por influencers. El servicio se dirige a un mercado de más de 26 millones de personas que se han sometido a pruebas de ascendencia genética, con DNA Expand enfocándose específicamente en los clientes de pruebas de ascendencia existentes.

ProPhase Labs는 건강, 웰빙 및 조상 통찰력을 제공하는 포괄적인 전체 유전체 시퀀싱을 제공하는 DNA Complete의 출시를 발표했습니다. 이 서비스에는 고급 생물 정보학, 유전 상담 및 구독 모델이 포함됩니다. 또한, 그들은 사용자가 연간 $49.95의 구독을 통해 기존의 DNA 조상 데이터를 50배 더 많은 정보로 확장할 수 있게 해주는 DNA Expand를 도입했습니다.

회사는 Barstool Sports의 전 임원인 Stu Hollenshead를 마케팅 노력을 이끌도록 임명했으며 인플루언서 중심의 캠페인을 계획하고 있습니다. 이 서비스는 유전 조상 테스트를 받은 2,600만 명 이상의 시장을 대상으로 하며, DNA Expand는 기존 조상 테스트 고객에 특히 중점을 두고 있습니다.

ProPhase Labs a annoncé le lancement de DNA Complete, offrant un séquençage génomique complet avec des informations sur la santé, le bien-être et l'ascendance. Le service comprend une bioinformatique avancée, un conseil génétique et un modèle d'abonnement. De plus, ils ont présenté DNA Expand, permettant aux utilisateurs d'enrichir les données d'ascendance ADN existantes avec 50 fois plus d'informations grâce à un abonnement annuel de 49,95 $.

L'entreprise a nommé Stu Hollenshead, ancien cadre de Barstool Sports, pour diriger les efforts marketing et prévoit une campagne axée sur les influenceurs. Le service cible un marché de plus de 26 millions de personnes ayant déjà effectué des tests d'ascendance génétique, avec DNA Expand se concentrant spécifiquement sur les clients de tests d'ascendance existants.

ProPhase Labs gab die Einführung von DNA Complete bekannt, das umfassende Ganzgenom-Sequenzierung mit Gesundheits-, Wellness- und Herkunftsinformationen bietet. Der Service umfasst fortschrittliche Bioinformatik, genetische Beratung und ein Abonnement-Modell. Darüber hinaus haben sie DNA Expand vorgestellt, das es Nutzern ermöglicht, bestehende DNA-Herkunftsdaten mit 50-fach mehr Informationen über ein Jahresabonnement von 49,95 $ zu erweitern.

Das Unternehmen hat Stu Hollenshead, einen ehemaligen Executive von Barstool Sports, ernannt, um die Marketingbemühungen zu leiten, und plant eine von Influencern unterstützte Kampagne. Der Service richtet sich an einen Markt von mehr als 26 Millionen Menschen, die genetische Ahnenforschungstests durchgeführt haben, wobei DNA Expand speziell auf bestehende Kunden von Ahnenforschungstests abzielt.

Positive
  • Launch of DNA Complete offering comprehensive genome sequencing service
  • Introduction of DNA Expand subscription service at $49.95 annually with minimal costs and high margins
  • Large target market of 26+ million people who have taken ancestry tests
  • Strategic hire of experienced executive Stu Hollenshead for marketing
  • Flexible processing capabilities through subsidiary Nebula Genomics and other labs
Negative
  • New product launch requires market acceptance and penetration
  • Success dependent on effective marketing campaign execution
  • Competitive market with established players in genetic testing

Insights

The launch of DNA Complete and DNA Expand represents a strategic move into the lucrative direct-to-consumer genetic testing market. The key revenue drivers include:

  • A $49.95 annual subscription model for DNA Expand with minimal COGS, promising high margins
  • Access to a massive market of over 26 million existing ancestry test customers
  • Whole genome sequencing service with competitive pricing

The business model is particularly compelling due to its recurring revenue structure and the potential for high customer lifetime value through the subscription platform. The partnership with former Barstool Sports executive Stu Hollenshead and the planned influencer marketing campaign could drive significant customer acquisition, though marketing costs may impact initial profitability. For a company with a $40.6M market cap, successful penetration of even a small percentage of the target market could substantially impact revenues.

The technological differentiation of DNA Complete is significant. While traditional ancestry tests analyze DNA segments, this platform's whole genome sequencing provides comprehensive genetic data. The DNA Expand service's ability to enhance existing ancestry data by 50 times without additional sequencing is technically innovative and cost-effective. The flexible lab processing network, including Nebula Genomics, ensures scalability and operational efficiency. The platform's integration of genetic counseling services and continuous updates through the subscription model creates a sustainable competitive advantage in the growing genomics market.

Introduces DNA Expand Subscription Platform to Enrich Existing DNA Ancestry Data with Comprehensive Health Insights

GARDEN CITY, NY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and diagnostics company, today announced the launch of DNA Complete, Inc., a wholly owned subsidiary, offering a groundbreaking direct-to-consumer DNA test that sequences virtually 100% of a customer’s genome. This new service provides customers with in-depth insights into health, wellness, and ancestry.

DNA Complete – A New Paradigm in Direct-to-Consumer DNA Testing

  • Comprehensive Whole Genome Sequencing: Unlike traditional DNA Ancestry tests that analyze small snippets of DNA, DNA Complete offers a full genomic view, empowering customers with detailed health and wellness information alongside enhanced ancestry data.
  • Strategic Leadership Addition: ProPhase retained Stu Hollenshead, former Chief Business Officer and COO of Barstool Sports and current CEO of 10PMCurfew, to spearhead marketing efforts.
  • Influencer-Driven Marketing Campaign: A robust marketing initiative featuring top social media influencers is set to launch and aims to maximize reach and engagement.
  • Competitive Pricing and Robust Platform: DNA Complete is designed to offer a robust genetic user platform at competitive pricing which makes advanced genomic insights accessible to a wider audience.
  • Cutting-Edge Bioinformatics and Ancestry Analysis: The service leverages its advanced bioinformatics platform and introduces a proprietary, sophisticated ancestry platform.
  • Flexibility with Sample Processing: DNA Complete provides the flexibility to send samples to ProPhase Labs’ other wholly owned subsidiary, Nebula Genomics, as well as other leading genetics labs, ensuring the highest quality results and efficient pricing and turnaround times.
  • Continuous Engagement Through Subscription: The DNA Complete subscription service ensures ongoing customer engagement by providing regular updates and new insights. The subscription model is a high margin business that we expect will create longer term cash flow.
  • Genetic Counseling Services: To enhance the value proposition, DNA Complete offers genetic counseling to help customers interpret their data effectively.

DNA Expand – Enhancing Existing DNA Ancestry Data

  • Effortless Data Upload: Consumers can easily upload their DNA data from other ancestry tests to unlock ProPhase’s proprietary health and wellness reports.
  • Significant Data Expansion: Users’ existing DNA files are amplified with 50 times more data than available through traditional DNA ancestry tests, delivering more in-depth insights without the need for additional sequencing.
  • Flexible Subscription Options: Monthly and yearly subscriptions are available, with new reports added regularly to keep customers informed.
  • Significant Target Market: A recent estimate indicates that more than 26 million people worldwide have undergone genetic ancestry testing by direct-to-consumer (DTC) companies.1
  • High Margins with Minimal Costs: We will offer a subscription at $49.95 annually. Since no new sequencing is required, the cost of goods sold is minimal (primarily the cost of IT) and the margins should be substantial. Over the next few years, with minimal market penetration we would therefore expect significant revenues, gross profit and longer-term cash flow.

Executive Commentary

Jason Karkus, President of DNA Complete, commented, “We have been meticulously working on our marketing and media campaign for quite some time now, including developing a sophisticated website and streamlining logistics while optimizing our approach to consumers. With beta testing complete, we are thrilled and fully prepared to launch. We anticipate some additional fine-tuning in the coming weeks as we ramp up. Our collaboration with Stu Hollenshead has been tremendous. We expect DNA Complete to provide exceptional DNA-related products and services and DNA Expand to enhance ancestry customers’ existing data without the need for additional sequencing. Our target market for DNA Expand is approximately tens of millions of consumers globally who previously purchased an ancestry test. We believe this product has enormous potential and will ultimately be a significant cash flow generator for the Company.”

ProPhase Supplements and Equivir Launch

ProPhase Supplements will also leverage the marketing platforms established for DNA Complete and DNA Expand. The Company anticipates announcing final clinical results for Equivir within the current quarter, followed by an immediate online launch. Additional details will be shared in future press releases.

About ProPhase Labs

ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We believe we’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Our world-class CLIA labs and cutting-edge diagnostic technology provide wellness solutions for healthcare providers and consumers. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ subsidiaries and their strategic synergies highlight our potential for long-term value.

Forward Looking Statements

Except for the historical information contained herein, this document contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our strategy, plans, objectives and initiatives, including our expected timeline for launching DNA Complete and DNA Expand, our belief in the market potential for such product and services and their ability to significantly impact the consumer genetic testing market, our ability to make personal genome sequencing more financially accessible and provide our customers more comprehensive genetic insight than other DNA testing companies, and the perceived advantages of whole genome sequencing (WGS). Management believes that these forward-looking statements are reasonable as and when made. However, such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those projected in the forward-looking statements. These risks and uncertainties include but are not limited to our ability to obtain and maintain necessary regulatory approvals, general economic conditions, consumer demand for our products and services, challenges relating to entering into and growing new business lines, the competitive environment, and the risk factors listed from time to time in our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and any other SEC filings. The Company undertakes no obligation to update forward-looking statements except as required by applicable securities laws. Readers are cautioned that forward-looking statements are not guarantees of future performance and are cautioned not to place undue reliance on any forward-looking statements.

Media Relations and Institutional Investor Contact:
ProPhase Labs, Inc.
267-880-1111
investorrelations@prophaselabs.com

Retail Investor Relations Contact:
Renmark Financial Communications
John Boidman
514-939-3989
Jboidman@renmarkfinancial.com

Source: ProPhase Labs, Inc.

1Regalado A More than 26 million people have taken an at-home ancestry test. MIT Technology Review; 2019. https://www.technologyreview.com/2019/02/11/103446/more-than-26-million-people-have-taken-an-at-home-ancestry-test/. Accessed February 12, 2020.


FAQ

What is ProPhase Labs' new DNA Complete service offering?

DNA Complete (PRPH) is a comprehensive whole genome sequencing service that provides detailed health, wellness, and ancestry insights by analyzing virtually 100% of a customer's genome.

How much does ProPhase Labs' DNA Expand subscription cost?

ProPhase Labs (PRPH) offers DNA Expand at $49.95 annually, providing enhanced analysis of existing DNA ancestry data with 50 times more information than traditional tests.

What is the target market size for ProPhase Labs' DNA testing services?

ProPhase Labs (PRPH) targets a market of over 26 million people worldwide who have undergone genetic ancestry testing through direct-to-consumer companies.

Who is leading the marketing efforts for ProPhase Labs' DNA Complete?

Stu Hollenshead, former Chief Business Officer and COO of Barstool Sports and current CEO of 10PMCurfew, will lead the marketing efforts for DNA Complete (PRPH).

ProPhase Labs, Inc.

NASDAQ:PRPH

PRPH Rankings

PRPH Latest News

PRPH Stock Data

14.67M
20.54M
14.34%
7.64%
0.81%
Diagnostics & Research
Pharmaceutical Preparations
Link
United States of America
NEW YORK